Man Group
OPRX icon

Man Group’s OptimizeRx OPRX Stock Holding History

Man Group’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414K Buy
72,347
+33,406
+86% +$192K ﹤0.01% 2099
2026
Q1 		$245K Buy
+38,941
New +$362K ﹤0.01% 2254
2023
Q3 		– Sell
-22,093
Closed -$240K – 1729
2023
Q2 		$316K Buy
+22,093
New +$315K ﹤0.01% 1714

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Man Group's OPRX Position: Q2 2026 in Review

Man Group increased its OptimizeRx (OPRX) stake by 86% in Q2 2026, buying an estimated $192K and bringing the position to 72,347 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

Man Group first reported a position in OPRX in Q2 2023 and has held it in 3 quarters since. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Man Group held 72,347 shares of OptimizeRx worth $414K as of Q2 2026.
  • Man Group bought 33,406 OptimizeRx shares in Q2 2026, an estimated $192K.
  • OptimizeRx made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2099 holding.
  • Man Group first reported a position in OptimizeRx in Q2 2023 and has held it in 3 quarters since.
  • 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.